Director/PDMR Shareholding
Eco Animal Health Group Plc
Issue of Share Options
ECO Animal Health Group plc
(“ECO†or the “Companyâ€)
27 August 2015
The Company announces that on 26th August 2015, the Board granted new options to certain Directors and Non-Executive Directors of the Company under the Company’s executive share option scheme (“New Optionsâ€). The New Options will vest on 26th August 2018 and have been granted as follows:
Director | Â | Number of options granted | Â | Exercise price | |
Marc Loomes | 400,000 | £2.65 | |||
Brett Clemo | 250,000 | £2.65 | |||
Julia Trouse | 150,000 | £2.65 | |||
Kevin Stockdale | 150,000 | £2.65 | |||
David Danson | 30,000 | £2.65 | |||
Anthony Rawlinson | 30,000 | £2.65 |
The aggregate 1,010,000 New Options issued represents approximately 1.58 per cent of the Company’s existing issued share capital. Following the issue, the Company’s total voting rights remains unchanged at 63,861,996 ordinary shares of 5p each.
Enquiries | Â | |
ECO Animal Health Group plc | ||
Peter Lawrence, Executive Chairman | 020 8336 6190 | |
Marc Loomes, CEO | 020 8447 8899 | |
Spiro Financial | ||
Anthony Spiro | 020 8336 6196 | |
 | ||
Peel Hunt LLP (Nominated Adviser) | ||
Dan Webster, Richard Brown | 020 7418 8900 |
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150827005719/en/